Cancer therapy resistance from a spatial‐omics perspective
Clinical and Translational Medicine · 2025-07 · 15 (7)
DOI: 10.1002/ctm2.70396 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 17.07.2025. Verfasst von Yinghao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shanghai Medical College, The Human Phenome Institute, Zhangjiang-Fudan International Innovation Center, Center for Integrati…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Science and Technology Major Project, National Natural Science Foundation of China, National Key R&D Project of China.
Abstract (Originalsprache)
Cancer therapy resistance (CTR) remains a significant challenge in oncology. Traditional methods like imaging, liquid biopsies and conventional omics analyses provide valuable insights, but lack the spatial resolution to fully characterise heterogeneity of tumour and the tumour microenvironment (TME). Recent advancements in spatial omics technologies offer unprecedented insights into the spatial organisation of tumours and TME. In this review, we summarise current methodologies for CTR research and highlight how spatial omics technologies and computational methods are revolutionising our understanding of CTR mechanisms. We also summarise recent studies leveraging spatial omics to uncover novel insights into CTR across various cancer types and therapies and discuss future opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Shanghai Medical College, The Human Phenome Institute, Zhangjiang-Fudan International Innovation Center, Center for Integrative Spatial-Omics Research, Fudan University, Fudan University Shanghai…
- Shanghai Innovation Institute, Shanghai, China.
- Shanghai Academy of Artificial Intelligence for Science, Shanghai, China.
- Department of Orthopedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
- State Key Laboratory of Genome and Multi-omics Technologies, BGI Research, Shenzhen, China.
- Institute of Science and Technology for Brain-Inspired Intelligence, MOE Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, MOE Frontiers Center for Brain Science, Fudan University, Shanghai,…
ORCID-Profile: Yinghao Zhang, Liang Wu, Zhiyuan Yuan, Bin-Zhi Qian
Förderung
- Shanghai Municipal Science and Technology Major Project
- National Natural Science Foundation of China
- National Key R&D Project of China
- AI for Science Foundation of Fudan University
- Shenzhen Science and Technology Program
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Zhang, Y., Yang, C., Chen, X., Wu, L., Yuan, Z., Zhang, F., & Qian, B. Z. (2025). Cancer therapy resistance from a spatial‐omics perspective. Clinical and Translational Medicine, 15(7). https://doi.org/10.1002/ctm2.70396
Vancouver
Zhang Y, Yang C, Chen X, Wu L, Yuan Z, Zhang F, et al. Cancer therapy resistance from a spatial‐omics perspective. Clinical and Translational Medicine. 2025;15(7). doi:10.1002/ctm2.70396
BibTeX
@article{Zhang2025,
author = {Zhang, Yinghao and Yang, Cheng and Chen, Xi and Wu, Liang and Yuan, Zhiyuan and Zhang, Fan and Qian, Bin-Zhi},
title = {Cancer therapy resistance from a spatial‐omics perspective},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {7},
doi = {10.1002/ctm2.70396}
}
EUVIMED